Skip to main content
. Author manuscript; available in PMC: 2017 May 23.
Published in final edited form as: Receptors Clin Investig. 2016 May 23;3(2):e1310.

Figure 5. MVP is glutathionylated.

Figure 5

(A) Human bronchial smooth muscle cells were transfected with thioredoxin-interacting protein (TXNIP) siRNA and treated with platelet-derived growth factor (PDGF). (B) Cells were transfected with siRNA to knockdown glutaredoxin 1 (Grx1). Cell lysates were immunoprecipitated with the glutathione (GSH) antibody, followed by immunoblotting with the MVP antibody. Bar graphs represent means ± SEM. * denotes values significantly different from the control, and ** denotes values significantly different from each other at P<0.05. Reprinted with permission [2].